drugset / Trial / NCT03686085

Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.

NCT03686085

Phase 3 Completed 200 enrolled Cairo University
RandomizedParallel-groupDouble-blindPrevention

Summary

To investigate whether vaginal dinoprostone administered before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications and pain in nulliparous women.

Timeline

Start
2018-09-30
Primary completion
2019-03-01
Completion
2019-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Other